M. Chehani Alles

841 total citations
9 papers, 583 citations indexed

About

M. Chehani Alles is a scholar working on Genetics, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, M. Chehani Alles has authored 9 papers receiving a total of 583 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Genetics, 4 papers in Molecular Biology and 3 papers in Pulmonary and Respiratory Medicine. Recurrent topics in M. Chehani Alles's work include Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (2 papers) and Respiratory and Cough-Related Research (2 papers). M. Chehani Alles is often cited by papers focused on Estrogen and related hormone effects (5 papers), Breast Cancer Treatment Studies (2 papers) and Respiratory and Cough-Related Research (2 papers). M. Chehani Alles collaborates with scholars based in Australia, Netherlands and Germany. M. Chehani Alles's co-authors include Marina Baquerizo Martinez, Peter R. Reeves, Ruiting Lan, Margaret Gardiner‐Garden, Robert L. Sutherland, Elizabeth A. Musgrove, Christopher J. Ormandy, Bandana Saini, Deborah Burton and Kate LeMay and has published in prestigious journals such as PLoS ONE, Infection and Immunity and Molecular Endocrinology.

In The Last Decade

M. Chehani Alles

9 papers receiving 569 citations

Peers

M. Chehani Alles
Letitia C. Fulcher United States
Bevin C. English United States
Adela Cota‐Gomez United States
José Luis Realpe United States
Dhiren Patel United States
M. Chehani Alles
Citations per year, relative to M. Chehani Alles M. Chehani Alles (= 1×) peers Siddhartha Majumdar

Countries citing papers authored by M. Chehani Alles

Since Specialization
Citations

This map shows the geographic impact of M. Chehani Alles's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Chehani Alles with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Chehani Alles more than expected).

Fields of papers citing papers by M. Chehani Alles

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Chehani Alles. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Chehani Alles. The network helps show where M. Chehani Alles may publish in the future.

Co-authorship network of co-authors of M. Chehani Alles

This figure shows the co-authorship network connecting the top 25 collaborators of M. Chehani Alles. A scholar is included among the top collaborators of M. Chehani Alles based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Chehani Alles. M. Chehani Alles is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Armour, Carol, Helen K. Reddel, Kate LeMay, et al.. (2012). Feasibility and Effectiveness of an Evidence-Based Asthma Service in Australian Community Pharmacies: A Pragmatic Cluster Randomized Trial. Journal of Asthma. 50(3). 302–309. 90 indexed citations
2.
Armour, Carol, Kate LeMay, Bandana Saini, et al.. (2011). Using the Community Pharmacy to Identify Patients at Risk of Poor Asthma Control and Factors which Contribute to this Poor Control. Journal of Asthma. 48(9). 914–922. 56 indexed citations
3.
Hilton, Heidi N., Mark J. Cowley, M. Chehani Alles, et al.. (2010). The Antiproliferative Effects of Progestins in T47D Breast Cancer Cells Are Tempered by Progestin Induction of the ETS Transcription Factor Elf5. Molecular Endocrinology. 24(7). 1380–1392. 11 indexed citations
4.
Alles, M. Chehani, Margaret Gardiner‐Garden, David J. Nott, et al.. (2009). Meta-Analysis and Gene Set Enrichment Relative to ER Status Reveal Elevated Activity of MYC and E2F in the “Basal” Breast Cancer Subgroup. PLoS ONE. 4(3). e4710–e4710. 79 indexed citations
5.
Rasiah, Krishan, Margaret Gardiner‐Garden, Emma J.D. Padilla, et al.. (2008). HSD17B4 overexpression, an independent biomarker of poor patient outcome in prostate cancer. Molecular and Cellular Endocrinology. 301(1-2). 89–96. 44 indexed citations
6.
Musgrove, Elizabeth A., C. Marcelo Sergio, Claire K. Inman, et al.. (2008). Identification of Downstream Targets of Estrogen and c-myc in Breast Cancer Cells. Advances in experimental medicine and biology. 617. 445–451. 10 indexed citations
7.
Musgrove, Elizabeth A., C. Marcelo Sergio, Sherene Loi, et al.. (2008). Identification of Functional Networks of Estrogen- and c-Myc-Responsive Genes and Their Relationship to Response to Tamoxifen Therapy in Breast Cancer. PLoS ONE. 3(8). e2987–e2987. 87 indexed citations
8.
McNeil, Catriona M., C. Marcelo Sergio, Claire K. Inman, et al.. (2006). c-Myc overexpression and endocrine resistance in breast cancer. The Journal of Steroid Biochemistry and Molecular Biology. 102(1-5). 147–155. 70 indexed citations
9.
Lan, Ruiting, et al.. (2004). Molecular Evolutionary Relationships of Enteroinvasive Escherichia coli and Shigella spp. Infection and Immunity. 72(9). 5080–5088. 136 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026